triazolam

PubChem Notes:

Triazolam A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Molecular Formula: C17H12Cl2N4


InChI: InChI=1/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3

InChIKey: InChIKey=JOFWLTCLBGQGBO-UHFFFAOYAU
SMILES: CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl

Names:
    CCRIS 1932
    Clorazolam
    DEA No. 2887
    Halcion
    HSDB 6759
    Novidorm
    Songar
    Triazolamum [INN-Latin]
    Triazolam [USAN:BAN:INN:JAN]
    triazolam

Registries:
    PubChem CID 5556
    PubChem ID 176103